Treatment and outcome of biopsy-proven fulminant myocarditis in adults

被引:11
|
作者
Chau, EMC [1 ]
Chow, WH
Chlu, CSW
Wang, E
机构
[1] Grantham Hosp, Dept Cardiol, Aberdeen, Hong Kong, Peoples R China
[2] Grantham Hosp, Dept Cardiothorac Surg, Hong Kong, Hong Kong, Peoples R China
[3] Grantham Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
关键词
fulminant myocarditis; endomyocardial biopsy; immunosuppression; mechanical circulatory support;
D O I
10.1016/j.ijcard.2005.07.082
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fulminant myocarditis may be rapidly fatal with severe haemodynamic compromise in previously healthy patients. We reviewed our experience with eight cases of biopsy-proven fulminant myocarditis (seven cases with lymphocytic myocarditis and one with eosinophilic myocarditis). Immunosuppression was given in seven out of eight cases. Mechanical circulatory support was required in 50% of the patients. Time from onset of illness to recovery of ventricular function varied from 12 to 17 days. All except one patient were alive at a mean follow-up of 4.4 years after the acute illness. Patients with acute fulminant myocarditis should be treated aggressively with immunosuppression and, if necessary, mechanical circulatory support during the first 2 to 3 weeks of the illness because of the reversible nature of this illness and good long-term prognosis. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:405 / 406
页数:2
相关论文
共 50 条
  • [31] Epicardial and microvascular coronary artery spasm in biopsy-proven viral myocarditis
    Seitz, Andreas
    Pereyra, Valeria Martinez
    Hubert, Astrid
    Klingel, Karin
    Bekeredjian, Raffi
    Sechtem, Udo
    Ong, Peter
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2022, 360 : 1 - 4
  • [32] Biopsy-Proven Fulminant Myocarditis Requiring Mechanical Circulatory Support Following Third Dose of COVID-19 MRNA Vaccination
    Hamaya, T.
    Sato, T.
    Kobayashi, Y.
    Mori, Y.
    Kamiya, K.
    Otsuka, N.
    Nagai, T.
    Anzai, T.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S359 - S360
  • [33] Immunosuppressive therapy and prognosis in biopsy-proven fulminant lymphocytic myocarditis requiring veno-arterial extracorporeal membranous oxygenation support
    Okumura, T.
    Sawamura, A.
    Kondo, T.
    Ito, M.
    Ozaki, Y.
    Ohte, N.
    Amano, T.
    Murohara, T.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 1388 - 1388
  • [34] Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis
    Anzini, Marco
    Merlo, Marco
    Sabbadini, Gastone
    Barbati, Giulia
    Finocchiaro, Gherardo
    Pinamonti, Bruno
    Salvi, Alessandro
    Perkan, Andrea
    Di Lenarda, Andrea
    Bussani, Rossana
    Bartunek, Jozef
    Sinagra, Gianfranco
    [J]. CIRCULATION, 2013, 128 (22) : 2384 - 2394
  • [35] Acute hemodynamic effects of metoprolol ± nitroglycerin in patients with biopsy-proven lymphocytic myocarditis
    Popovic, Z
    Miric, M
    Vasiljevic, J
    Sagic, D
    Bojic, M
    Popovic, AD
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (06): : 801 - 804
  • [36] Biopsy-Proven Giant Cell Myocarditis Following the COVID-19 Vaccine
    Sung, Kevin
    McCain, Julia
    King, Kevin R.
    Hong, Kimberly
    Aisagbonhi, Omonigho
    Adler, Eric D.
    Urey, Marcus A.
    [J]. CIRCULATION-HEART FAILURE, 2022, 15 (04) : 414 - 417
  • [37] GA-67 IMAGING IN PATIENTS WITH DILATED CARDIOMYOPATHY AND BIOPSY-PROVEN MYOCARDITIS
    OCONNELL, JB
    HENKIN, RE
    ROBINSON, JA
    SUBRAMANIAN, R
    SCANLON, PJ
    GUNNAR, RM
    [J]. CIRCULATION, 1984, 70 (01) : 58 - 62
  • [38] Biopsy-Proven Myocarditis: Gender Differences and Serum Autoantibody Markers of Dismal Prognosis
    Caforio, Alida I.
    Testolina, Martina
    Schiavo, Alessandro
    Marra, Martina Perazzolo
    Bilato, Claudio
    Marcolongo, Renzo
    Angelini, Annalisa
    Basso, Cristina
    Panfili, Marco
    Brugnaro, Luca
    Tarantini, Giuseppe
    Napodano, Massimo
    Bottaro, Stefania
    Fabozzo, Assunta
    Isabella, Giambattista
    Razzolini, Renato
    Thiene, Gaetano
    Gerosa, Gino
    Iliceto, Sabino
    [J]. CIRCULATION, 2012, 126 (21)
  • [39] BIOPSY-PROVEN DIFFUSE MIDLINE GLIOMA IN ADOLESCENTS AND YOUNG ADULTS
    Tanaka, Shota
    Takayanagi, Shunsaku
    Shinya, Yuki
    Kawashima, Mariko
    Shin, Masahiro
    Nakatomi, Hirofumi
    Saito, Nobuhito
    [J]. NEURO-ONCOLOGY, 2020, 22 : 290 - 290
  • [40] Predictors of Incident Cardiovascular Disease in Adults with Biopsy-Proven NAFLD
    Henson, Jacqueline
    Simon, Tracey G.
    Kaplan, Aly
    Osganian, Stephanie
    Nath, Cheryl
    Corey, Kathleen E.
    [J]. HEPATOLOGY, 2018, 68 : 972A - 973A